Moser M, Menz G, Blaser K, Crameri R
Swiss Institute of Allergy and Asthma Research, Davos-Platz.
Infect Immun. 1994 Mar;62(3):936-42. doi: 10.1128/iai.62.3.936-942.1994.
A 32-kDa nonglycosylated alkaline protease (EC 3.4.1.14) with elastolytic activity, secreted by the opportunistic pathogen Aspergillus fumigatus ATCC 42202, is suggested to be a virulence factor of this fungus. The enzyme is a serine protease of the subtilisin family, and its cDNA nucleotide sequence has recently been reported. We have cloned the cDNA encoding the mature protease into a high-level Escherichia coli expression plasmid and produced the recombinant protease as a fusion protein with a six-adjacent-histidine affinity tag at the carboxy terminus. Subsequently, the recombinant protease was purified to homogeneity, with affinity chromatography yielding 30 to 40 mg of recombinant protease per liter of E. coli culture. Refolded recombinant protease, in comparison with native protease, demonstrated weak enzymatic activity but similar immunochemical characteristics as analyzed by antigen-specific enzyme-linked immunosorbent assay (ELISA), competition ELISA, and immunoblotting assays. To assess the allergenic potential of the protease, sera from patients with allergic bronchopulmonary aspergillosis and sera from healthy control individuals were analyzed by ELISA and immunoblotting techniques. Sera from patients with allergic bronchopulmonary aspergillosis did not have protease-specific immunoglobulin E (IgE) antibodies and, remarkably, did not show significantly elevated protease-specific IgG antibody levels compared with those in sera from healthy control individuals. This suggests that the alkaline protease from A. fumigatus does not elicit IgE antibodies and has weak immunogenicity, a property which may explain fungus persistence in allergic individuals.
由机会致病菌烟曲霉ATCC 42202分泌的一种具有弹性蛋白酶活性的32 kDa非糖基化碱性蛋白酶(EC 3.4.1.14)被认为是该真菌的一种毒力因子。该酶是枯草杆菌蛋白酶家族的丝氨酸蛋白酶,其cDNA核苷酸序列最近已有报道。我们已将编码成熟蛋白酶的cDNA克隆到一个高效大肠杆菌表达质粒中,并产生了一种在羧基末端带有六个相邻组氨酸亲和标签的重组蛋白酶融合蛋白。随后,通过亲和层析将重组蛋白酶纯化至同质,每升大肠杆菌培养物可产生30至40毫克重组蛋白酶。通过抗原特异性酶联免疫吸附测定(ELISA)、竞争ELISA和免疫印迹分析,与天然蛋白酶相比,重折叠的重组蛋白酶显示出较弱的酶活性,但具有相似的免疫化学特性。为了评估该蛋白酶的致敏潜力,采用ELISA和免疫印迹技术分析了过敏性支气管肺曲霉病患者的血清和健康对照个体的血清。过敏性支气管肺曲霉病患者的血清中没有蛋白酶特异性免疫球蛋白E(IgE)抗体,而且与健康对照个体血清相比,蛋白酶特异性IgG抗体水平也没有显著升高。这表明烟曲霉的碱性蛋白酶不会引发IgE抗体,且免疫原性较弱,这一特性可能解释了真菌在过敏个体中的持续存在。